Drug retargeting is the discovery of leads and drug candidates via the identification of previously unrecognized molecular activities of approved and investigational drugs.

nPharmakon's breakthrough, clinically validated drug retargeting technology offers a new and economical way to accelerate and de-risk drug discovery and development.